Charles Schwab Investment Management Inc Amicus Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,667,271 shares of FOLD stock, worth $25.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,667,271
Previous 2,424,599
10.01%
Holding current value
$25.6 Million
Previous $24.1 Million
18.44%
% of portfolio
0.01%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding FOLD
# of Institutions
311Shares Held
312MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$276 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$269 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$233 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$230 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$222 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.69B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...